News for Intercept Pharma Stock (ICPT)

SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc.– ICPT

GlobeNewsWire • 12/09/20

ICPT STOCK DEADLINE: Zhang Investor Law Reminds Investors with Losses of the Deadline in Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. – ICPT

GlobeNewsWire • 12/08/20

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ICPT

PRNewsWire • 12/08/20

ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ICPT

Business Wire • 12/05/20

Notice of Lead Plaintiff Deadline for Shareholders in the Intercept Pharmaceuticals, Inc. Class Action Lawsuit

Business Wire • 12/03/20

ROSEN, A TOP RANKED LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ICPT

Newsfile Corp • 12/02/20

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ICPT

GlobeNewsWire • 12/01/20

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT

GlobeNewsWire • 11/26/20

ROSEN, A LEADING LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - ICPT

PRNewsWire • 11/25/20

Intercept to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

GlobeNewsWire • 11/24/20

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPT

Business Wire • 11/20/20

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Intercept Pharmaceuticals, Inc. (ICPT) Investors

PRNewsWire • 11/18/20

ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - ICPT

Newsfile Corp • 11/17/20

ICPT Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Intercept Pharmaceuticals, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: January 4, 2021

Business Wire • 11/17/20

New Data from the Interim Analysis of REGENERATE Show OCA Improved Noninvasive Measures of Fibrosis in a Subgroup of High-Risk Patients with Fibrosis Due to NASH

GlobeNewsWire • 11/16/20

ROSEN, RESPECTED INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - ICPT

PRNewsWire • 11/14/20

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. (ICPT)

Business Wire • 11/13/20

Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Intercept Pharmaceuticals, Inc. (ICPT) and January 4 Lead Plaintiff Deadline

Business Wire • 11/13/20

The Brualdi Law Firm, P.C. Announces Class Action Lawsuit against Intercept Pharmaceuticals, Inc.

Newsfile Corp • 11/13/20

DEADLINE FOR ICPT INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc.

Newsfile Corp • 11/12/20

Intercept's (ICPT) Q3 Loss Wider Than Expected, Sales Beat

Zacks Investment Research • 11/10/20

Intercept Pharmaceuticals, Inc. (ICPT) CEO Mark Pruzanski on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha • 11/09/20

Why Investors Loved Intercept Pharmaceuticals' Q3 Update

The Motley Fool • 11/09/20

Intercept Pharmaceuticals: Q3 Earnings Insights

Benzinga • 11/09/20

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Intercept Pharmaceuticals, Inc. (ICPT) Investors

Business Wire • 11/06/20